US Bancorp’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$53.5K Sell
310
-5
-2% -$863 ﹤0.01% 2748
2025
Q1
$49.1K Sell
315
-46
-13% -$7.17K ﹤0.01% 2753
2024
Q4
$49.7K Buy
361
+73
+25% +$10.1K ﹤0.01% 2740
2024
Q3
$43K Sell
288
-22
-7% -$3.29K ﹤0.01% 2812
2024
Q2
$42.3K Sell
310
-6
-2% -$818 ﹤0.01% 2752
2024
Q1
$47.8K Buy
316
+32
+11% +$4.84K ﹤0.01% 2724
2023
Q4
$35.8K Buy
284
+74
+35% +$9.32K ﹤0.01% 2830
2023
Q3
$19.7K Buy
210
+48
+30% +$4.5K ﹤0.01% 2883
2023
Q2
$14.5K Sell
162
-901
-85% -$80.4K ﹤0.01% 3096
2023
Q1
$114K Sell
1,063
-145
-12% -$15.5K ﹤0.01% 2122
2022
Q4
$148K Sell
1,208
-45
-4% -$5.5K ﹤0.01% 2018
2022
Q3
$130K Buy
1,253
+283
+29% +$29.4K ﹤0.01% 2059
2022
Q2
$90K Buy
970
+357
+58% +$33.1K ﹤0.01% 2283
2022
Q1
$72K Sell
613
-142
-19% -$16.7K ﹤0.01% 2425
2021
Q4
$101K Sell
755
-164
-18% -$21.9K ﹤0.01% 2290
2021
Q3
$146K Buy
919
+166
+22% +$26.4K ﹤0.01% 2085
2021
Q2
$99K Sell
753
-63
-8% -$8.28K ﹤0.01% 2305
2021
Q1
$106K Buy
816
+153
+23% +$19.9K ﹤0.01% 2233
2020
Q4
$111K Buy
663
+11
+2% +$1.84K ﹤0.01% 2151
2020
Q3
$101K Sell
652
-351
-35% -$54.4K ﹤0.01% 2067
2020
Q2
$148K Buy
1,003
+401
+67% +$59.2K ﹤0.01% 1897
2020
Q1
$68K Buy
602
+217
+56% +$24.5K ﹤0.01% 2157
2019
Q4
$53K Buy
385
+217
+129% +$29.9K ﹤0.01% 2442
2019
Q3
$16K Buy
168
+21
+14% +$2K ﹤0.01% 2915
2019
Q2
$17K Buy
147
+16
+12% +$1.85K ﹤0.01% 2933
2019
Q1
$15K Buy
131
+55
+72% +$6.3K ﹤0.01% 2943
2018
Q4
$5K Hold
76
﹤0.01% 3192
2018
Q3
$5K Hold
76
﹤0.01% 3302
2018
Q2
$5K Hold
76
﹤0.01% 3300
2018
Q1
$5K Hold
76
﹤0.01% 3305
2017
Q4
$3K Hold
76
﹤0.01% 3400
2017
Q3
$3K Hold
76
﹤0.01% 3345
2017
Q2
$2K Hold
76
﹤0.01% 3376
2017
Q1
$2K Hold
76
﹤0.01% 3379
2016
Q4
$2K Buy
+76
New +$2K ﹤0.01% 3368